LevensonAJ. Psychotropic drug use in the elderly: An overview. Am Fam Physician1981; 24: 194–9.
2.
LevensonAJBellerSA. Psychotropic drug use in the elderly: Optimal technique. Urban Health1983; 12: 29–37.
3.
KirvenLEMonteroEF. Comparison of thioridazine and diazepam in the control of nonpsychotic symptoms associated with senility: Double-blind study. J Am Geriatr Soc1973; 21: 546–51.
4.
MaurerAS. Management of emotional disturbances in geriatric patients. J Am Geriatr Soc1973; 21: 226–8.
5.
GanguliR. The rational use of psychotropic drugs. Urban Health1983; 12: 42–8.
6.
DanielR. Psychiatric drug use and abuse in the aged. Geriatrics1970; 25: 144–5.
7.
CovertABRodriguesTSolomonK. The use of mechanical and chemical restraints in nursing homes. J Am Geriatr Soc1977; 25: 85–9.
8.
HollisterLEKosekJC. Sudden death during treatment with phenothiazine derivatives. JAMA1965; 192: 1035–8.
9.
LeestmaJEKoenigKL. Sudden death and phenothiazines. Arch Gen Psychiatry1968; 18: 137–48.
10.
SmegoRADurackDT. The neuroleptic malignant syndrome. Arch Intern Med1982; 142: 1183–5.
LitvakPKaeblingR. Agranulocytosis, leukopenia and psychotropic drugs. Arch Gen Psychiatry1971; 24: 265–7.
13.
DucombLBaldessariniRJ. Timing and risk of bone marrow depression by psychotropic drugs. Am J Psychiatry1977; 134: 1294–5.
14.
LipscombPA. Cardiovascular side effects of phenothiazines and tricyclic antidepressants. Postgrad Med1980; 67 (3): 189–92.
15.
KemperAJDunlapRPietroDA. Thioridazine-induced torsade de pointes. JAMA1983; 249: 2931–4.
16.
KaneJMSmithJM. Tardive dyskinesia. Arch Gen Psychiatry1982; 39: 473–81.
17.
JesteDV. Tardive dyskinesia—reversible and persistent. Arch Gen Psychiatry1979; 36: 585–90.
18.
JesteDVLinnoilaMWagnerRLWyattRJ. Serum neuroleptic concentrations and tardive dyskinesia. Psychopharmacology1982; 76: 377–80.
19.
SweetCColeJOShapiroSSloneD. Extrapyramidal side effects in chlorpromazine recipients—emergence according to benztropine prophylaxis. Arch Gen Psychiatry1977; 34: 942–3.
20.
EreshefskyLStimmelGL. Psychoses. In: KatcherBSYoungLYKoda-KimbleMA, eds. Applied therapeutics: The clinical use of drugs. 3rd ed. Spokane: Applied Therapeutics, 1983: 1000–6.
21.
TepperSJHaasJF. Prevalence of tardive dyskinesia. J Clin Psychiatry1979; 40: 508–16.
22.
HicksRDyskenMWDavisJMLesserJRipeckyjALazarusL. The pharmacokinetics of psychotropic medication in the elderly: A review. J Clin Psychiatry1981; 42: 374–85.
23.
EisdorferC. Observations on the psychopharmacology of the aged. J Am Geriatr Soc1975; 23: 53–7.
24.
PrienRFHaberPACaffeyEM. The use of psychoactive drugs in elderly patients with psychiatric disorders: Survey conducted in twelve Veterans Administration hospitals. J Am Geriatr Soc1975; 23: 104–12.
25.
KalchthalerTCoccaroELichtigerS. Incidence of polypharmacy in a long-term care facility. J Am Geriatr Soc1977; 25: 308–13.
26.
FracchiaJSheppardCMerlisS. Combination medications in psychiatric treatment: Patterns in a group of elderly hospital patients. J Am Geriatr Soc1971; 19: 301–7.
27.
MannAHJenkinsRCrossPSGurlandBJ. A comparison of the prescriptions received by the elderly in long-term care in New York and London. Psychol Med1984; 14: 891–7.
28.
ZawadskiRTGlazerGBLurieE. Psychotropic drug use among institutionalized and noninstitutionalized Medicaid aged in California. J Gerontol1978; 33: 825–34.
29.
IngmanSRLawsonIRPierpaeliPG. A survey of the prescribing and administration of drugs in long-term care institutions for the elderly. J Am Geriatr Soc1975; 23: 309–16.
30.
RobersPA. Extent of medication use in U.S. long-term care facilities. Am J Hosp Pharm1988; 45: 93–100.
31.
RayWAFererspielCFSchaffnerW. A study of antipsychotic drug use in nursing homes: Epidemiological evidence suggesting misuse. Am J Public Health1980; 70: 485–91.
32.
BuckJA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc1988; 36: 409–18.
33.
BeersMAvornJSoumeraiSB. Psychoactive medication use in intermediate-care facility residents. JAMA1988; 260: 3016–20.
34.
AvornJDreyerPConnellyKSoumeraiSB. Use of psychoactive medication and the quality of care in rest homes. N Engl J Med1989; 320: 227–32.
35.
GuyW. ECDEU assessment manual for psychopharmacology. Rev. ed.Washington, DC: U.S. Department of Health, Education, and Welfare, 1976.
36.
MunetzMRBenjaminS. How to examine patients using the abnormal involuntary movement scale. Hosp Comm Psychiatry1988; 39: 1172–7.
37.
Health Care Financing Administration. Department of Health and Human Services. BERC-396-P. Sec. 483.25. Fed Regvol. 52, No. 200, 16 October 1987.
38.
CraneGESmeetsRA. Tardive dyskinesia and drug therapy in geriatric patients. Arch Gen Psychiatry1974; 30: 341–3.